CLINICAL_TRIALS
trial_result
· 2019-05-22
Clinical Trial Update: Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema [Phase 2]
Summary
Phase 2 clinical trial update evaluating Alzer and Diamel to prevent severe diabetic macular edema.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catalysis SL | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED